“One Less” Market for Merck to Push Its HPV Drug

Kaiser Health Disparities Report: A Weekly Look At Race, Ethnicity And Health

Kaiser Network

Politics & Policy | CDC To Review Vaccine Policies; Immigrant, Women’s Rights Advocates Anticipating Repeal of HPV Vaccine Requirement
[May 11, 2009]

A coalition of more than 100 groups representing women, immigrants, and public health and reproductive rights advocates are hoping CDC will repeal its rule requiring female immigrants seeking U.S. citizenship to receive the human papillomavirus vaccine Gardasil, the AP/Newark Star-Ledger reports (Garay, AP/Newark Star-Ledger, 5/7). The vaccine, approved by FDA in 2006 and recommended by CDC’s Advisory Committee on Immunization Practices, prevents transmission of HPV strains responsible for 70% of cervical cancer and 90% of genital warts. Gardasil was added to an updated list of immigration vaccines in July 2008 and the policy went into effect Aug. 1 (Kaiser Health Disparities Report, 10/2/08). CDC has been conducting an ongoing review of the requirement, and the public comment period ended on Friday.


Comment from Leslie
Guess that might be “One Less” market for Merck to push its HPV drug.


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.